Alkem Laboratories

Alkem Laboratories, a pharmaceutical preparation manufacturing company headquartered in India, is actively addressing its carbon footprint. For the financial year ending 2025, the company reported total Scope 1 and 2 emissions of approximately 109.1 million kg CO2e. This comprises approximately 33.0 million kg CO2e from Scope 1 and about 76.1 million kg CO2e from Scope 2 emissions.

Looking at previous years, Alkem Laboratories' total emissions (Scope 1, 2, and 3) for the financial year ending 2024 were approximately 466.7 million kg CO2e. This included Scope 1 emissions of about 19.2 million kg CO2e, Scope 2 emissions of approximately 82.3 million kg CO2e, and a substantial Scope 3 contribution of around 365.2 million kg CO2e. For the financial year ending 2023, the total Scope 1 and 2 emissions were approximately 101.6 million kg CO2e.

Alkem Laboratories has set a significant climate commitment: to reduce its Scope 1 and 2 greenhouse gas (GHG) emissions by 42% by the financial year 2033, using the financial year 2023 as a base year. This target is classified as an absolute reduction and covers all scopes. The company's reporting indicates that it is currently on track to meet its near-term and five-year reduction goals. While Scope 3 emissions are significant, the data indicates that purchased goods and services within Scope 3 are a missing data point in the reporting for recent years.